1.09
Precedente Chiudi:
$1.09
Aprire:
$1.1
Volume 24 ore:
24,087
Relative Volume:
0.15
Capitalizzazione di mercato:
$48.54M
Reddito:
$63.15M
Utile/perdita netta:
$-40.30M
Rapporto P/E:
-0.6527
EPS:
-1.67
Flusso di cassa netto:
$-44.47M
1 W Prestazione:
-4.39%
1M Prestazione:
-6.84%
6M Prestazione:
-49.07%
1 anno Prestazione:
-62.54%
Tela Bio Inc Stock (TELA) Company Profile
Nome
Tela Bio Inc
Settore
Industria
Telefono
484-320-2930
Indirizzo
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Confronta TELA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
TELA
Tela Bio Inc
|
1.09 | 48.54M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
125.92 | 219.41B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.64 | 145.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.54 | 140.43B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.53 | 126.52B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 49.08B | 5.88B | 1.34B | 799.60M | 2.3489 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | Iniziato | Lake Street | Buy |
| 2019-12-03 | Iniziato | Canaccord Genuity | Buy |
| 2019-12-03 | Iniziato | JMP Securities | Mkt Outperform |
| 2019-12-03 | Iniziato | Jefferies | Buy |
| 2019-12-03 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Tela Bio Inc Borsa (TELA) Ultime notizie
How TELA Bio Inc. stock reacts to bond yields2025 Valuation Update & Fast Moving Market Watchlists - ulpravda.ru
Aug Action: How TELA Bio Inc. stock compares to growth peersQuarterly Profit Report & Community Verified Trade Signals - ulpravda.ru
Is TELA Bio Inc. stock in correction or buying zoneStock Market Trends & Build Winning Strategies With Zero Cost - ulpravda.ru
TELA Bio introduces LIQUIFIX for enhanced surgical precision - Traders Union
TELA Bio to Present at Canaccord Genuity 45th Annual Growth Conference - MSN
TELA Bio Appoints Healthcare Leader Betty Jo Rocchio to Board of Directors - MSN
Is It Too Late to Sell PVV Infra LimitedLong-Term Investment Plans & Outstanding Wealth Building - earlytimes.in
TELA Bio Inc Stock Analysis and ForecastVolatility Trading Techniques & Minimal Investment Profits - earlytimes.in
Movement Recap: How TELA Bio Inc stock reacts to bond yieldsJuly 2025 Sector Moves & Long-Term Safe Investment Ideas - moha.gov.vn
Small Medtech TELA Bio Takes On Becton Dickinson, Alleges Hernia Mesh Monopoly - Benzinga
Becton, Dickinson accused of hindering competition in hernia mesh market - MSN
Becton Muscles Out Hernia Mesh Rivals, Antitrust Suit Says - Law360
Tela Bio (TELA) Sues Becton, Dickinson Over Hernia Mesh Market P - GuruFocus
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly - Reuters
Is TELA Bio Inc. stock a top pick in earnings seasonWeekly Market Outlook & Smart Swing Trading Techniques - Улправда
How sustainable is TELA Bio Inc. stock dividend payoutQuarterly Portfolio Summary & Growth Focused Entry Point Reports - Улправда
Will TELA Bio Inc. stock continue dividend increasesWeekly Trading Summary & Reliable Breakout Stock Forecasts - Улправда
Becton Dickinson Faces Antitrust Suit Over Hernia Mesh Products - Bloomberg Law News
Whale Trades: Is TELA Bio Inc. stock a top pick in earnings seasonMarket Growth Review & Daily Stock Trend Watchlist - Улправда
Update Report: Is TELA Bio Inc. stock gaining market shareJuly 2025 Opening Moves & Safe Entry Momentum Tips - ulpravda.ru
TELA Bio signals growth with new-hire equity grants - MSN
Is TELA Bio Inc. stock gaining market shareTrade Volume Report & Risk Managed Investment Signals - Улправда
Canaccord Genuity Keeps Their Buy Rating on TELA Bio (TELA) - The Globe and Mail
TELA Bio Signals Growth With New-Hire Equity Grants - MyChesCo
TELA Bio Earnings Notes - Trefis
TELA Bio (TELA) price target decreased by 25.81% to 3.52 - MSN
Lake Street Keeps Their Buy Rating on TELA Bio (TELA) - The Globe and Mail
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Associated Press | syndication news - Enidnews.com
What analysts say about TELA Bio Inc stockTrading Volume Surges & High Return Capital Growth - earlytimes.in
TELA Bio, Inc. (NASDAQ:TELA) Receives $3.25 Consensus Price Target from Analysts - Defense World
Resistance Check: Is TELA Bio Inc stock gaining market shareMarket Performance Summary & Entry Point Strategy Guides - BỘ NỘI VỤ
TELA Bio (TELA) Stock Analysis Report | Financials & Insights - Benzinga
Adamas Trust, Inc. Announces Pricing of Public Offering of Senior Notes - The Globe and Mail
TELA Bio stock price target lowered to $3 by Lake Street on sales issues - Investing.com South Africa
Lake Street Maintains TELA Bio (TELA) Buy Recommendation - Nasdaq
Lake Street Lowers Price Target for TELA Bio (TELA) Amid Continued Buy Rating | TELA Stock News - GuruFocus
TELA Bio, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Performance - Markets Mojo
TELA Bio Set to Spotlight Soft-Tissue Innovations at Major Healthcare Conference - MSN
TELA Bio Unveils New Wave of Hiring With Stock Grants Tied to Growth Push - MSN
TELA Bio Posts Steady Growth as Strategic Shift Sparks New Commercial Momentum - MSN
Goodwin Advises TELA Bio On $13 Million Underwritten Registered Direct Offering And Credit Refinancing - Mondaq
How to track smart money flows in TELA Bio Inc.2025 AllTime Highs & Consistent Return Strategy Ideas - newser.com
Tela Bio Inc Azioni (TELA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):